Study Notes on Drug Receptor Interactions and Mechanisms of Action

Drug Receptor Interactions: Part 2

Agonists

  • Definition: An agonist is a molecule such as a hormone or neurotransmitter that binds to a receptor and elicits a response.

    • Illustration: Interaction illustrated with audio-visual cues: "KLIK" sound when the receptor is activated and "KLIK!" when the receptor is occupied.

Biological Response Measurement

  • Bioassays: The method used to measure the biological response of a living tissue to a drug, hormone, or other chemical entity.

    • Types of responses:

    • Contraction

    • Relaxation

    • In Vivo: Whole animals

    • In Vitro: Tissue/cells

    • Example: Response of bladder strips to increasing concentrations of carbachol in an organ bath.

Dose-Response Curves (DR Curves)

  • Purpose: Quantify the response of tissue to a drug.

  • Functions:

    • Allow estimation of maximum response (Emax).

    • Allow estimation of the concentration or dose required to produce 50% of maximal response (EC50 or ED50).

    • Allow determination of potency and efficacy.

Potency

  • Definition: Potency is an index measuring how much drug must be administered to elicit a desired response.

    • Characteristics:

    • Potent drugs elicit responses at lower concentrations compared to less potent drugs.

    • Measured by EC50 (the concentration of a drug that produces 50% of the maximum possible effect).

    • Clinical Significance: Potency alone has little clinical significance for a therapeutic effect. Higher potency does not imply clinical superiority—only that a lower dose is needed.

    • Low potency is problematic when the dosage becomes too cumbersome to administer (e.g., intravenous routes).

Agonist Comparison

  • Agonists A, B, and C helliptically presented with potency measured by EC50.

    • The agonist with the lowest EC50 is the most potent, suggested by the log10 scale.

Efficacy

  • Definition: Efficacy is the ability of an agonist to activate the receptor and trigger a biochemical response.

    • Significance: Refers to the maximal response that can be achieved in a tissue when an agonist binds to a receptor.

    • Classes of agonists based on their efficacy include:

    • Full agonists: Maximal efficacy (efficacy = 1).

    • Partial agonists: Sub-maximal responses even when all receptors are occupied (efficacy < 1).

Partial Agonists

  • Definition: Bind to receptors but evoke less than the maximum response when all receptors are occupied.

    • Characteristics:

    • Can demonstrate high affinity for the receptor.

    • Exhibit lower efficacy compared to full agonists, potentially acting as antagonists under specific conditions.

  • Understanding Partial Agonism:

    • Two-stage activation model: Receptor activation is graded rather than an all-or-nothing response, leading to partial activation.

  • Implications:

    • Can inhibit full agonist responses if the partial agonist binds with high affinity.

Dose-Response Curve Analysis

  • Efficacy vs. Potency: Efficacy is distinct from potency in pharmacodynamics:

    • Potency relates to how much drug is needed for a desired effect.

    • Efficacy relates to the extent of the effect achieved at maximal dosage.

    • Questions posed regarding the analysis of dose-response curves:

    • Can similar pain relief be achieved with different drugs?

    • Identifying which drug provides equivalent pain relief at lower doses by examining graph characteristics.

Clinically Useful Full Agonists

  • Notable examples included:

    • Salbutamol (Ventalin®): Beta 2 adrenoceptor agonist used for asthma treatment.

    • Morphine (Oramorph®): Opioid receptor agonist for moderate/severe pain relief.

    • Sumatriptan (Imigran®): Serotonin receptor agonist used for migraine episodes.

    • Ropinirole (Requip®): D2 dopamine receptor agonist for Parkinson's disease treatment.

Clinically Useful Partial Agonists

  • Including:

    • Buprenorphine (Subutex®): Opioid receptor partial agonist for opioid dependence treatment.

    • Buspirone (BuSpar®): Partial agonist at serotonin 5-HT1A receptors, predominantly for anxiety.

Inverse Agonists

  • Definition: Ligands that bind to receptors and decrease the fraction of receptors that are in an active conformation, reducing effect below baseline.

  • Pharmacology Overview:

    • A + R ⇌ AR ⇌ AR*

    • The two-state model reflects receptor activity.

    • Some receptors exhibit constitutive activity in the absence of agonists.

  • Examples:

    • Taranabant: Cannabinoid receptor inverse agonist; however, discontinued due to adverse effects.

    • β-Carbolines: Act on GABAA receptors, having anxiogenic properties.

EC50 and KD Comparison

  • Concept: EC50 does not equate to KD due to the presence of spare receptors in the system.

  • Example:

    • Acetylcholine can produce a ~100% response at approximately 50% receptor occupancy due to receptor reserve, indicating 100% occupancy isn't always necessary for maximal response.

Comparing Binding and Response Curves

  • Differences between binding curves (reflecting receptor occupancy) and response curves (indicating biological response) are noted, with emphasis on the role of second messengers in cellular signaling, amplifying effects at low occupancy.

Questions for Consideration

  • Occupancy-response relationships in drug interactions highlight differences in drug characteristics:

    • Identifying partial agonists among studied drugs.

    • Estimating receptor reserves of various drugs.

Summary of Key Concepts

  • Agonist Activity: Measured by both potency and efficacy.

    • Potency describes dosage required for effect.

    • Efficacy defines the response generated by the agonist-receptor complex.

  • Classifications:

    • Full agonists possess maximal efficacy (efficacy = 1).

    • Partial agonists yield sub-maximal effects (efficacy < 1).

    • Inverse agonists stabilize receptors in a resting state, reducing constitutive activity.

  • Receptor Reserve: Addresses how 100% receptor occupancy is not necessarily required for maximum responses, illustrating the concept of spare receptors.